135 related articles for article (PubMed ID: 29210332)
1. Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.
Randesi M; van den Brink W; Levran O; Yuferov V; Blanken P; van Ree JM; Ott J; Kreek MJ
Pharmacogenomics; 2018 Jan; 19(2):95-104. PubMed ID: 29210332
[TBL] [Abstract][Full Text] [Related]
2. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
3. VMAT2 gene (
Randesi M; van den Brink W; Levran O; Blanken P; van Ree JM; Ott J; Kreek MJ
Pharmacogenomics; 2019 Apr; 20(5):331-341. PubMed ID: 30983500
[No Abstract] [Full Text] [Related]
4. Dopamine D1 receptor gene variation modulates opioid dependence risk by affecting transition to addiction.
Zhu F; Yan CX; Wen YC; Wang J; Bi J; Zhao YL; Wei L; Gao CG; Jia W; Li SB
PLoS One; 2013; 8(8):e70805. PubMed ID: 23976958
[TBL] [Abstract][Full Text] [Related]
5. High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.
Moran M; Blum K; Ponce JV; Lott L; Gondré-Lewis MC; Badgaiyan S; Brewer R; Downs BW; Fynman P; Weingarten A; Cadet JL; Smith DE; Baron D; Thanos PK; Modestino EJ; Badgaiyan RD; Elman I; Gold MS
Mol Neurobiol; 2021 Jul; 58(7):3335-3346. PubMed ID: 33683627
[TBL] [Abstract][Full Text] [Related]
6. Association of functional DBH genetic variants with alcohol dependence risk and related depression and suicide attempt phenotypes: results from a large multicenter association study.
Preuss UW; Wurst FM; Ridinger M; Rujescu D; Fehr C; Koller G; Bondy B; Wodarz N; Soyka M; Zill P
Drug Alcohol Depend; 2013 Dec; 133(2):459-67. PubMed ID: 23906995
[TBL] [Abstract][Full Text] [Related]
7. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
[TBL] [Abstract][Full Text] [Related]
8. 'Food addiction' and its association with a dopaminergic multilocus genetic profile.
Davis C; Loxton NJ; Levitan RD; Kaplan AS; Carter JC; Kennedy JL
Physiol Behav; 2013 Jun; 118():63-9. PubMed ID: 23680433
[TBL] [Abstract][Full Text] [Related]
9. Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship.
Punchaichira TJ; Dey SK; Mukhopadhyay A; Kundu S; Thelma BK
Neurogenetics; 2017 Jul; 18(3):155-168. PubMed ID: 28707163
[TBL] [Abstract][Full Text] [Related]
10. Translational Studies of Sex Differences in Sensitivity to Opioid Addiction.
Chartoff EH; McHugh RK
Neuropsychopharmacology; 2016 Jan; 41(1):383-4. PubMed ID: 26657961
[No Abstract] [Full Text] [Related]
11. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.
Kosten TR; Wu G; Huang W; Harding MJ; Hamon SC; Lappalainen J; Nielsen DA
Biol Psychiatry; 2013 Feb; 73(3):219-24. PubMed ID: 22906516
[TBL] [Abstract][Full Text] [Related]
12. Common and specific liability to addiction: approaches to association studies of opioid addiction.
Nielsen DA; Kreek MJ
Drug Alcohol Depend; 2012 Jun; 123 Suppl 1(0 1):S33-41. PubMed ID: 22542464
[TBL] [Abstract][Full Text] [Related]
13. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium.
Polimanti R; Walters RK; Johnson EC; McClintick JN; Adkins AE; Adkins DE; Bacanu SA; Bierut LJ; Bigdeli TB; Brown S; Bucholz KK; Copeland WE; Costello EJ; Degenhardt L; Farrer LA; Foroud TM; Fox L; Goate AM; Grucza R; Hack LM; Hancock DB; Hartz SM; Heath AC; Hewitt JK; Hopfer CJ; Johnson EO; Kendler KS; Kranzler HR; Krauter K; Lai D; Madden PAF; Martin NG; Maes HH; Nelson EC; Peterson RE; Porjesz B; Riley BP; Saccone N; Stallings M; Wall TL; Webb BT; Wetherill L; ; Edenberg HJ; Agrawal A; Gelernter J
Mol Psychiatry; 2020 Aug; 25(8):1673-1687. PubMed ID: 32099098
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.
Cilia R; Benfante R; Asselta R; Marabini L; Cereda E; Siri C; Pezzoli G; Goldwurm S; Fornasari D
Parkinsonism Relat Disord; 2016 Aug; 29():96-103. PubMed ID: 27237108
[TBL] [Abstract][Full Text] [Related]
15. Genetic Vulnerability to Opioid Addiction.
Reed B; Kreek MJ
Cold Spring Harb Perspect Med; 2021 Jun; 11(6):. PubMed ID: 32205416
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine Hydroxylase Gene Polymorphisms Contribute to Opioid Dependence and Addiction by Affecting Promoter Region Function.
Liu JL; Li SQ; Zhu F; Zhang YX; Wu YN; Yang JS; Zhang B; Yan CX
Neuromolecular Med; 2020 Sep; 22(3):391-400. PubMed ID: 32232669
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.
López-Moreno JA; López-Jiménez A; Gorriti MA; de Fonseca FR
Curr Drug Targets; 2010 Apr; 11(4):406-28. PubMed ID: 20196742
[TBL] [Abstract][Full Text] [Related]
18. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.
Hess C; Reif A; Strobel A; Boreatti-Hümmer A; Heine M; Lesch KP; Jacob CP
J Neural Transm (Vienna); 2009 Feb; 116(2):121-30. PubMed ID: 18982239
[TBL] [Abstract][Full Text] [Related]
19. Positive association between--1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users.
Xie X; Xu L; Liu H; Chen W; Zhuang D; Zhang J; Duan S; Zhou W
Neurosci Lett; 2013 Apr; 541():258-62. PubMed ID: 23510745
[TBL] [Abstract][Full Text] [Related]
20. Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.
Fang Y; Ji N; Cao Q; Su Y; Chen M; Wang Y; Yang L
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):625-32. PubMed ID: 26447643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
